Literature DB >> 27501828

An overview of the bacterial contribution to Crohn disease pathogenesis.

Moftah H Alhagamhmad1, Andrew S Day1,2, Daniel A Lemberg1,3, Steven T Leach1.   

Abstract

Crohn disease (CD) is a chronic inflammatory condition primarily affecting the gastro-intestinal tract and is characterized by reduced bacterial diversity. The exact cause of disease is unknown; however, evidence suggests that several components, including microbiota, may contribute to the underlying pathology and disease development. Perturbation of the host-microbe commensal relationship is considered the main driving force of tissue destruction and pathological changes seen in CD. Several putative bacterial pathogens including species from Mycobacterium, Campylobacter and Helicobacter are postulated in the aetiology of CD. However, to date, no strong evidence supports a single bacterium contributing overall to CD pathogenesis. Alternatively, dysbiosis or bacterial imbalance is more widely accepted as a leading factor in the disrupted host-immune system cross-talk resulting in subsequent intestinal inflammation. Depletion of symbiont microbes including Firmicutes, Bifidobacterium and Clostridia, in conjunction with an increase in pathobiont microbes from Bacteroidetes and Enterobacteria, is a striking feature observed in CD. No single factor has been identified as driving this dysbiosis, although diet, antibiotic exposure and possible early life events in presence of underlying genetic susceptibility may contribute. The aim of this review is to highlight the current accumulating literature on the proposed role of bacteria in the pathogenesis of CD.

Entities:  

Mesh:

Year:  2016        PMID: 27501828     DOI: 10.1099/jmm.0.000331

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  28 in total

1.  Loss of RHBDF2 results in an early-onset spontaneous murine colitis.

Authors:  Ramasatyaveni Geesala; Willow Schanz; Mikayla Biggs; Garima Dixit; Joseph Skurski; Prajwal Gurung; David K Meyerholz; David Elliott; Priya D Issuree; Thorsten Maretzky
Journal:  J Leukoc Biol       Date:  2019-01-29       Impact factor: 4.962

2.  Decreased Enteric Bacterial Composition and Diversity in South American Crohn's Disease Vary With the Choice of Treatment Strategy and Time Since Diagnosis.

Authors:  Angélica Cruz-Lebrón; Leticia D'argenio Garcia; Aarthi Talla; Samira Joussef-Piña; Miguel E Quiñones-Mateu; Rafick-Pierre Sékaly; Karina Inacio Ladislau de Carvalho; Alan D Levine
Journal:  J Crohns Colitis       Date:  2020-07-09       Impact factor: 9.071

Review 3.  Kono-S anastomosis for Crohn's disease: a systemic review, meta-analysis, and meta-regression.

Authors:  Cheng Han Ng; Yip Han Chin; Snow Yunni Lin; Jeffery Wei Heng Koh; Bettina Lieske; Frederick Hong-Xiang Koh; Choon Seng Chong; Fung Joon Foo
Journal:  Surg Today       Date:  2020-09-07       Impact factor: 2.549

4.  Automatic identification of optimal marker genes for phenotypic and taxonomic groups of microorganisms.

Authors:  Elad Segev; Zohar Pasternak; Tom Ben Sasson; Edouard Jurkevitch; Mira Gonen
Journal:  PLoS One       Date:  2018-05-02       Impact factor: 3.240

Review 5.  The microbiome in inflammatory bowel diseases: from pathogenesis to therapy.

Authors:  Sheng Liu; Wenjing Zhao; Ping Lan; Xiangyu Mou
Journal:  Protein Cell       Date:  2020-06-29       Impact factor: 14.870

Review 6.  Are Escherichia coli Pathotypes Still Relevant in the Era of Whole-Genome Sequencing?

Authors:  Roy M Robins-Browne; Kathryn E Holt; Danielle J Ingle; Dianna M Hocking; Ji Yang; Marija Tauschek
Journal:  Front Cell Infect Microbiol       Date:  2016-11-18       Impact factor: 5.293

7.  Fecal microbiota transplantation induces remission of infantile allergic colitis through gut microbiota re-establishment.

Authors:  Sheng-Xuan Liu; Yin-Hu Li; Wen-Kui Dai; Xue-Song Li; Chuang-Zhao Qiu; Meng-Ling Ruan; Biao Zou; Chen Dong; Yan-Hong Liu; Jia-Yi He; Zhi-Hua Huang; Sai-Nan Shu
Journal:  World J Gastroenterol       Date:  2017-12-28       Impact factor: 5.742

Review 8.  Role of Gut Microbiota in Rheumatoid Arthritis.

Authors:  Yuichi Maeda; Kiyoshi Takeda
Journal:  J Clin Med       Date:  2017-06-09       Impact factor: 4.241

Review 9.  The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn's Disease: A Review.

Authors:  Amber MacLellan; Jessica Moore-Connors; Shannan Grant; Leah Cahill; Morgan G I Langille; Johan Van Limbergen
Journal:  Nutrients       Date:  2017-05-01       Impact factor: 5.717

10.  The Crohn's disease-related bacterial strain LF82 assembles biofilm-like communities to protect itself from phagolysosomal attack.

Authors:  Victoria Prudent; Gaëlle Demarre; Emilie Vazeille; Maxime Wery; Nicole Quenech'Du; Antinéa Ravet; Julie Dauverd-Girault; Erwin van Dijk; Marie-Agnès Bringer; Marc Descrimes; Nicolas Barnich; Sylvie Rimsky; Antonin Morillon; Olivier Espéli
Journal:  Commun Biol       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.